Cargando…

Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms

The discovery of the HD (Huntington’s disease) gene in 1993 led to the creation of genetic mouse models of the disease and opened the doors for mechanistic studies. In particular, the early changes and progression of the disease could be followed and examined systematically. The present review focus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cepeda, Carlos, Cummings, Damian M, André, Véronique M, Holley, Sandra M, Levine, Michael S
Formato:	Texto
Lenguaje:	English
Publicado:	American Society for Neurochemistry 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850512/ https://www.ncbi.nlm.nih.gov/pubmed/20396376 http://dx.doi.org/10.1042/AN20090058

Ejemplares similares

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease
por: Cummings, Damian M, et al.
Publicado: (2010)

Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington’s Disease
por: Holley, S. M., et al.
Publicado: (2022)

Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington’s Disease Mice
por: Botelho, Eliã P., et al.
Publicado: (2014)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease
por: Gu, Xiaofeng, et al.
Publicado: (2007)

Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease1,2,3
por: Holley, Sandra M., et al.
Publicado: (2015)

Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice
por: Holley, Sandra M., et al.
Publicado: (2019)

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease
por: André, Véronique M., et al.
Publicado: (2011)

Neuronal Targets of Mutant Huntingtin Genetic Reduction to Ameliorate Huntington’s Disease Pathogenesis in Mice
por: Wang, Nan, et al.
Publicado: (2014)

Calcium imaging: A versatile tool to examine Huntington’s disease mechanisms and progression
por: Barry, Joshua, et al.
Publicado: (2022)

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
por: Chen, Jane Y., et al.
Publicado: (2013)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function
por: Ho Kim, Soong, et al.
Publicado: (2011)

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
por: Chen, Jane Y., et al.
Publicado: (2013)

Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation
por: Turner, Lauren M., et al.
Publicado: (2015)

High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease
por: Balci, Fuat, et al.
Publicado: (2013)

Cardiac Dysfunction in the BACHD Mouse Model of Huntington’s Disease
por: Schroeder, Analyne M., et al.
Publicado: (2016)

Huntington’s Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support
por: Garcia, Veronica J., et al.
Publicado: (2019)

Putting the Brakes on Huntington Disease in a Mouse Experimental Model
por: Kim, Jane C., et al.
Publicado: (2015)

Dissecting the Contribution of Individual Receptor Subunits to the Enhancement of N-methyl-d-Aspartate Currents by Dopamine D1 Receptor Activation in Striatum
por: Jocoy, Emily L., et al.
Publicado: (2011)

Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington’s disease.
por: Schroeder, Analyne M., et al.
Publicado: (2011)

D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
por: Lim, Soyeon, et al.
Publicado: (2011)

White Matter Loss in a Mouse Model of Periventricular Leukomalacia Is Rescued by Trophic Factors
por: Espinosa-Jeffrey, Araceli, et al.
Publicado: (2013)

Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE‐HD study
por: Turner, Lauren M., et al.
Publicado: (2016)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development?
por: Leuchter, Michael K., et al.
Publicado: (2017)

Early alteration of epigenetic-related transcription in Huntington’s disease mouse models
por: Hervás-Corpión, Irati, et al.
Publicado: (2018)

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
por: Franco-Iborra, Sandra, et al.
Publicado: (2018)

Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington’s disease
por: Ragot, Alienor, et al.
Publicado: (2015)

Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model
por: Gallardo-Orihuela, Andrea, et al.
Publicado: (2019)

Targeted Genetic Reduction of Mutant Huntingtin Lessens Cardiac Pathology in the BACHD Mouse Model of Huntington's Disease
por: Park, Saemi, et al.
Publicado: (2021)

Global Rhes knockout in the Q175 Huntington’s disease mouse model
por: Heikkinen, Taneli, et al.
Publicado: (2021)

Gait dynamics in mouse models of Parkinson's disease and Huntington's disease
por: Amende, Ivo, et al.
Publicado: (2005)

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2014)

Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)

Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease
por: Cutler, Tamara S., et al.
Publicado: (2017)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
por: Rose, Claudia, et al.
Publicado: (2010)

Striatal Pre-Enkephalin Overexpression Improves Huntington’s Disease Symptoms in the R6/2 Mouse Model of Huntington’s Disease
por: Bissonnette, Stéphanie, et al.
Publicado: (2013)

Astrocytic engagement of the corticostriatal synaptic cleft is disrupted in a mouse model of Huntington’s disease
por: Villanueva, Carlos Benitez, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4q522ifl1p11iaf317ndrpav9g